Taking advantage of all these findings and the Kaplan–Meier survival curves summarized in Figure 1, studies using synthetic ligands or natural molecules that are devoid of side effects and that modulate PPARγ signaling should be planned for the management of breast cancer. This evidence concerns the gene PPARG and breast carcinoma.